Adjuvant approach will need confirmation from ongoing phase III trial, says expert ...

Doctors followed standard testing guidelines, which recommend discontinuing screenings for men over 70 years old. Should that ...

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, and Vanderbilt Health today announce data from a Phase 2a ...

Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...

Johnson & Johnson (J&J) has announced results from the final analysis of the phase 3 PROTEUS study showing that Erleada ...

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

Local recurrence was high in soft-tissue metastatic complete responders. However, patients who received radiation at bony ...

High-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone therapy before and ...

Phase 3 ROADS enrolled 204 patients across 32 centers (2021–2025) with 2–7 cm brain metastases, comparing tile-based intraoperative radiation versus external stereotactic radiation. Surgical bed ...

A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that implanting collagen tiles during brain surgery to deliver targeted radiation therapy ...